Article
Usefulness of mirtazapine and SSRIs in late-life depression. Post hoc analysis of the GUNDAM study.
2023-02-22
Abstract excerpt
<h4>Objective: </h4> Mirtazapine and SSRIs are widely prescribed as first-line agents for late-life depression. However, evidence for these drugs is mostly based on non-elderly patients. Therefore, we reanalyzed a randomized controlled trial of mirtazapine versus SSRIs for depression in a sub-population of late-life patients. <h4>Methods: </h4> A randomized controlled trial was conducted with 141 patients, of who...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 8cc86298-a574-5aed-9845-0c0a4f73c97c
- DOI
- 10.21203/rs.3.rs-2589875/v1
